Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05502861 · ClinicalTrials.gov registry record · NA

A Pragmatic Trial of an Active Choice Nudge for Generalist or Specialist Palliative Care for Seriously Ill Inpatients

A NA study of Palliative Care, sponsored by University of Pennsylvania.

Active
Registry status
NA
Development phase
16,000
Enrollment target
1
Study location

NCT05502861: Active NA study of Palliative Care, sponsored by University of Pennsylvania.

NCT05502861 is a NA study of Palliative Care that is active but no longer recruiting, run by University of Pennsylvania. The registered enrollment target is 16,000 participants, above the 527-participant average among 18 other Palliative Care trials with a reported enrollment target (2936% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05502861, a NA study of Palliative Care, is active but no longer recruiting, sponsored by University of Pennsylvania.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
16,000 participants
Enrollment target
1
Study location

Study Summary

This stepped-wedge, cluster-randomized pragmatic trial among six hospitals at University of Pennsylvania Health System will test a behavioral intervention embedded within the electronic health record that nudges hospital clinicians to either provide palliative care (PC) themselves (generalist PC) or consult specialists (specialty PC) for inpatients at high risk of death within 6 months. The trial will evaluate the intervention's effect compared to usual care on the primary outcome of hospital-free days through 6 months, and other patient-centered, clinical, and economic outcomes. The trial also includes an embedded mixed methods study to understand clinician and hospital contextual factors that influence the intervention's uptake.

Primary Outcome

Days from enrollment spent alive and not in an acute care hospital through 6 months or death

Conditions Studied

Interventions

  • BEHAVIORAL Generalist + Specialist palliative care
  • BEHAVIORAL Pre-Intervention phase

Study Locations (1)

Pennsylvania

  • University of Pennsylvania - Philadelphia

Trial Details

FieldValue
Enrollment Target 16,000 participants
Start Date 2023-11-13
Est. Completion 2026-06
Phase NA
University of Pennsylvania

1,423 total trials

What the registry record for NCT05502861 still lists

NCT05502861 is an interventional study that assigns participants to a tested intervention. Its 16,000 participants enrollment target places it among the larger protocols in the corpus, above the 527-participant average among 18 other Palliative Care trials with a reported enrollment target (2936% higher).

The record links to 1 condition, with Palliative Care appearing as the primary indexed condition, and to 2 interventions - of which Generalist + Specialist palliative care is the first listed.

NCT05502861 reports a single indexed study location in Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT05502861 about?

NCT05502861 is a clinical study titled "A Pragmatic Trial of an Active Choice Nudge for Generalist or Specialist Palliative Care for Seriously Ill Inpatients". This stepped-wedge, cluster-randomized pragmatic trial among six hospitals at University of Pennsylvania Health System will test a behavioral intervention embedded within the electronic health record that nudges hospital clinicians to either provide palliative care (PC) themselves (generalist PC) or...

What is the current status of trial NCT05502861?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 16,000 participants. The study started on 2023-11-13. Estimated completion is 2026-06.

What conditions does trial NCT05502861 study?

This clinical trial studies the following conditions: Palliative Care.

What interventions are being tested in trial NCT05502861?

The interventions under investigation include: Generalist + Specialist palliative care (BEHAVIORAL), Pre-Intervention phase (BEHAVIORAL).

Who is sponsoring clinical trial NCT05502861?

This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05502861 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Palliative Care

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05502861's enrollment target sits among peer trials

16,000 1st of 18 higher than 18 of 18 other Palliative Care trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Palliative Care trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01737528 · 16,000 participants

    STS/ACC Transcatheter Valve Therapy Registry (TVT Registry)

  • NCT06380114 · 16,000 participants · NA

    Stand Up 2 HPV: Standing Orders to Improve HPV Vaccination

  • NCT05447806 · 15,732 participants · NA

    Diabetes Clinical Decision Support

  • NCT06951867 · 16,640 participants

    Tezspire Cardiac Events PASS

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05502861, the US trial registry maintained by the National Library of Medicine. NCT05502861 (large enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.